229 related articles for article (PubMed ID: 33058214)
1. A murine model of eosinophilic chronic rhinosinusitis using the topical application of a vitamin D3 analog.
Kagoya R; Kondo K; Kishimoto-Urata M; Shimizu Y; Kikuta S; Yamasoba T
Allergy; 2021 May; 76(5):1432-1442. PubMed ID: 33058214
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Interferon-β Response Contributes to Eosinophilic Chronic Rhinosinusitis.
Jang YJ; Lim JY; Kim S; Lee Y; Kweon MN; Kim JH
Front Immunol; 2018; 9():2330. PubMed ID: 30455684
[TBL] [Abstract][Full Text] [Related]
3. IL-17A facilitates type 2 inflammation in a modified eosinophilic chronic rhinosinusitis mouse model.
Wu H; Wang Z; Li X; Chen X; Li Y; Huang W; Chang L; Zhang G
Int Forum Allergy Rhinol; 2023 Sep; 13(9):1726-1737. PubMed ID: 36716409
[TBL] [Abstract][Full Text] [Related]
4. Activation of STAT6 by intranasal allergens correlated with the development of eosinophilic chronic rhinosinusitis in a mouse model.
Wei H; Xu L; Sun P; Xing H; Zhu Z; Liu J
Int J Immunopathol Pharmacol; 2022; 36():3946320221109529. PubMed ID: 35726645
[TBL] [Abstract][Full Text] [Related]
5. Development of a mouse model of eosinophilic chronic rhinosinusitis with nasal polyp by nasal instillation of an Aspergillus protease and ovalbumin.
Kim HC; Lim JY; Kim S; Kim JH; Jang YJ
Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):3899-3906. PubMed ID: 28828551
[TBL] [Abstract][Full Text] [Related]
6. γδT cells contribute to type 2 inflammatory profiles in eosinophilic chronic rhinosinusitis with nasal polyps.
Li X; Wang Z; Chang L; Chen X; Yang L; Lai X; Li S; Huang J; Huang Z; Wu X; Bellanti JA; Zheng SG; Zhang G
Clin Sci (Lond); 2019 Nov; 133(22):2301-2315. PubMed ID: 31722010
[TBL] [Abstract][Full Text] [Related]
7. Expression and Functional Analysis of CST1 in Intractable Nasal Polyps.
Kato Y; Takabayashi T; Sakashita M; Imoto Y; Tokunaga T; Ninomiya T; Morikawa T; Yoshida K; Noguchi E; Fujieda S
Am J Respir Cell Mol Biol; 2018 Oct; 59(4):448-457. PubMed ID: 29698614
[TBL] [Abstract][Full Text] [Related]
8. IL-21 induces pyroptosis of Treg cells via Akt-mTOR-NLRP3-caspase 1 axis in eosinophilic chronic rhinosinusitis.
Chang L; Wu H; Huang W; Li Y; Chen Y; Li X; Yao Z; Chen X; Lai X; Zheng R; Huang Z; Wu X; Zhang G
J Allergy Clin Immunol; 2023 Sep; 152(3):641-655.e14. PubMed ID: 37164271
[TBL] [Abstract][Full Text] [Related]
9. IL-5 and IL-6 are increased in the frontal recess of eosinophilic chronic rhinosinusitis patients.
Kubota K; Takeno S; Taruya T; Sasaki A; Ishino T; Hirakawa K
J Otolaryngol Head Neck Surg; 2017 May; 46(1):36. PubMed ID: 28464955
[TBL] [Abstract][Full Text] [Related]
10. Epithelial Cell-Derived Cytokines Contribute to the Pathophysiology of Eosinophilic Chronic Rhinosinusitis.
Kouzaki H; Matsumoto K; Kato T; Tojima I; Shimizu S; Shimizu T
J Interferon Cytokine Res; 2016 Mar; 36(3):169-79. PubMed ID: 26540312
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and expression of thymic stromal lymphopoetin in eosinophilic and non-eosinophilic chronic rhinosinusitis.
Ouyang Y; Fan E; Li Y; Wang X; Zhang L
ORL J Otorhinolaryngol Relat Spec; 2013; 75(1):37-45. PubMed ID: 23571727
[TBL] [Abstract][Full Text] [Related]
12. Group 2 innate lymphoid cells and eosinophilic chronic rhinosinusitis.
Tojima I; Shimizu T
Curr Opin Allergy Clin Immunol; 2019 Feb; 19(1):18-25. PubMed ID: 30507713
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Effects of Intranasal Tofacitinib on Chronic Rhinosinusitis with Nasal Polyps in Mice.
Joo YH; Cho HJ; Jeon YJ; Kim JH; Jung MH; Jeon SY; Suh YS; Park JJ; Kim SW
Laryngoscope; 2021 May; 131(5):E1400-E1407. PubMed ID: 32990335
[TBL] [Abstract][Full Text] [Related]
14. Postoperative evaluation of olfactory dysfunction in eosinophilic chronic rhinosinusitis - comparison of histopathological and clinical findings.
Kashiwagi T; Tsunemi Y; Akutsu M; Nakajima I; Haruna S
Acta Otolaryngol; 2019 Oct; 139(10):881-889. PubMed ID: 31438745
[No Abstract] [Full Text] [Related]
15. Which are the best murine models to study Eosinophilic Chronic Rhinosinusitis? A contemporary review.
Leite-Santos F; Tamashiro E; de Andrade Batista Murashima A; Anselmo-Lima WT; Valera FCP
Braz J Otorhinolaryngol; 2023; 89(6):101328. PubMed ID: 37734174
[TBL] [Abstract][Full Text] [Related]
16. High chemokine ligand 11 levels in nasal lavage fluid: A potential predictor of and therapeutic target for murine eosinophilic chronic rhinosinusitis.
Ren X; Wang Z
Life Sci; 2021 Apr; 271():119218. PubMed ID: 33592198
[TBL] [Abstract][Full Text] [Related]
17. The effect of calprotectin on TSLP and IL-25 production from airway epithelial cells.
Kato T; Kouzaki H; Matsumoto K; Hosoi J; Shimizu T
Allergol Int; 2017 Apr; 66(2):281-289. PubMed ID: 27475624
[TBL] [Abstract][Full Text] [Related]
18. Induction of peripheral lymph node addressin in human nasal mucosa with eosinophilic chronic rhinosinusitis.
Tsutsumiuchi T; Hoshino H; Fujieda S; Kobayashi M
Pathology; 2019 Apr; 51(3):268-273. PubMed ID: 30837082
[TBL] [Abstract][Full Text] [Related]
19. CCL4 Regulates Eosinophil Activation in Eosinophilic Airway Inflammation.
Chu HH; Kobayashi Y; Bui DV; Yun Y; Nguyen LM; Mitani A; Suzuki K; Asako M; Kanda A; Iwai H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555793
[TBL] [Abstract][Full Text] [Related]
20. Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis.
Yamada T; Miyabe Y; Ueki S; Fujieda S; Tokunaga T; Sakashita M; Kato Y; Ninomiya T; Kawasaki Y; Suzuki S; Saito H
Front Immunol; 2019; 10():74. PubMed ID: 30778348
[No Abstract] [Full Text] [Related]
[Next] [New Search]
